These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
489 related articles for article (PubMed ID: 11854157)
21. Induction and suppression of cytochrome P450 1A by 3,3',4,4',5-pentachlorobiphenyl and its relationship to oxidative stress in the marine fish scup (Stenotomus chrysops). Schlezinger JJ; Stegeman JJ Aquat Toxicol; 2001 Apr; 52(2):101-15. PubMed ID: 11164533 [TBL] [Abstract][Full Text] [Related]
22. Cytochrome P450 1A-dependent activities in deer, cattle and horses. Darwish WS; Ikenaka Y; Eldaly EA; Ohno M; Sakamoto KQ; Fujita S; Ishizuka M J Vet Med Sci; 2010 May; 72(5):561-6. PubMed ID: 20068271 [TBL] [Abstract][Full Text] [Related]
23. Methoxyresorufin: an inappropriate substrate for CYP1A2 in the mouse. Hamm JT; Ross DG; Richardson VM; Diliberto JJ; Birnbaum LS Biochem Pharmacol; 1998 Dec; 56(12):1657-60. PubMed ID: 9973187 [TBL] [Abstract][Full Text] [Related]
24. Preferential inhibition of CYP1A enzymes in hepatic microsomes by mexiletine. Konishi H; Morita K; Minouchi T; Yamaji A Eur J Drug Metab Pharmacokinet; 1999; 24(2):149-53. PubMed ID: 10510742 [TBL] [Abstract][Full Text] [Related]
25. Determination of cytochrome P450 1A activities in mammalian liver microsomes by high-performance liquid chromatography with fluorescence detection. Hanioka N; Tatarazako N; Jinno H; Arizono K; Ando M J Chromatogr B Biomed Sci Appl; 2000 Jul; 744(2):399-406. PubMed ID: 10993529 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of CYP1 by berberine, palmatine, and jatrorrhizine: selectivity, kinetic characterization, and molecular modeling. Lo SN; Chang YP; Tsai KC; Chang CY; Wu TS; Ueng YF Toxicol Appl Pharmacol; 2013 Nov; 272(3):671-80. PubMed ID: 23886934 [TBL] [Abstract][Full Text] [Related]
27. Metabolic activation of the indoloquinazoline alkaloids evodiamine and rutaecarpine by human liver microsomes: dehydrogenation and inactivation of cytochrome P450 3A4. Wen B; Roongta V; Liu L; Moore DJ Drug Metab Dispos; 2014 Jun; 42(6):1044-54. PubMed ID: 24696463 [TBL] [Abstract][Full Text] [Related]
28. Differential activities of CYP1A isozymes in hepatic and intestinal microsomes of control and 3-methylcholanthrene-induced rats. Spatzenegger M; Horsmans Y; Verbeeck RK Pharmacol Toxicol; 2000 Feb; 86(2):71-7. PubMed ID: 10728918 [TBL] [Abstract][Full Text] [Related]
29. EROD and MROD as Markers of Cytochrome P450 1A Activities in Hepatic Microsomes from Entire and Castrated Male Pigs. Zamaratskaia G; Zlabek V Sensors (Basel); 2009; 9(3):2134-47. PubMed ID: 22574004 [TBL] [Abstract][Full Text] [Related]
30. Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes. Yamazaki H; Nakano M; Gillam EM; Bell LC; Guengerich FP; Shimada T Biochem Pharmacol; 1996 Jul; 52(2):301-9. PubMed ID: 8694855 [TBL] [Abstract][Full Text] [Related]
31. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2. Tassaneeyakul W; Birkett DJ; Veronese ME; McManus ME; Tukey RH; Quattrochi LC; Gelboin HV; Miners JO J Pharmacol Exp Ther; 1993 Apr; 265(1):401-7. PubMed ID: 8474022 [TBL] [Abstract][Full Text] [Related]
32. Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1. Doostdar H; Burke MD; Mayer RT Toxicology; 2000 Apr; 144(1-3):31-8. PubMed ID: 10781868 [TBL] [Abstract][Full Text] [Related]
33. Contribution of CYP1A1 and CYP1A2 to the activation of heterocyclic amines in monkeys and human. Edwards RJ; Murray BP; Murray S; Schulz T; Neubert D; Gant TW; Thorgeirsson SS; Boobis AR; Davies DS Carcinogenesis; 1994 May; 15(5):829-36. PubMed ID: 8200083 [TBL] [Abstract][Full Text] [Related]
34. Further immunochemical and biocatalytic characterization of CYP1A1 from feral leaping mullet liver (Liza saliens) microsomes. Sen A; Arinç E Comp Biochem Physiol C Toxicol Pharmacol; 2000 Jul; 126(3):235-44. PubMed ID: 11048673 [TBL] [Abstract][Full Text] [Related]
35. In vivo cimetidine inhibits hepatic CYP2C6 and CYP2C11 but not CYP1A1 in adult male rats. Levine M; Law EY; Bandiera SM; Chang TK; Bellward GD J Pharmacol Exp Ther; 1998 Feb; 284(2):493-9. PubMed ID: 9454789 [TBL] [Abstract][Full Text] [Related]
36. Detailed characterization of experimentally derived human hepatic CYP1A1 activity and expression using differential inhibition of ethoxyresorufin O-deethylation by fluvoxamine. Sy SK; Tang BK; Pastrakuljic A; Roberts EA; Kalow W Eur J Clin Pharmacol; 2001 Aug; 57(5):377-86. PubMed ID: 11599655 [TBL] [Abstract][Full Text] [Related]
37. Effects of curcumin on cytochrome P450 and glutathione S-transferase activities in rat liver. Oetari S; Sudibyo M; Commandeur JN; Samhoedi R; Vermeulen NP Biochem Pharmacol; 1996 Jan; 51(1):39-45. PubMed ID: 8534266 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of human CYP1A2 activity in vitro by methylxanthines: potent competitive inhibition by 8-phenyltheophylline. Murray S; Odupitan AO; Murray BP; Boobis AR; Edwards RJ Xenobiotica; 2001 Mar; 31(3):135-51. PubMed ID: 11465391 [TBL] [Abstract][Full Text] [Related]
39. Metabolic activation of dacarbazine by human cytochromes P450: the role of CYP1A1, CYP1A2, and CYP2E1. Reid JM; Kuffel MJ; Miller JK; Rios R; Ames MM Clin Cancer Res; 1999 Aug; 5(8):2192-7. PubMed ID: 10473105 [TBL] [Abstract][Full Text] [Related]